Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Head and Neck Cancer

  Free Subscription


23.03.2026

4 BMC Cancer
1 BMC Surg
1 Br J Cancer
1 Br J Oral Maxillofac Surg
1 Cancer Res
3 Clin Cancer Res
1 Dis Esophagus
1 Gastrointest Endosc
4 Head Neck
1 Int J Cancer
2 Int J Radiat Oncol Biol Phys
5 J Clin Endocrinol Metab
2 J Clin Oncol
8 Laryngoscope
5 Oral Oncol
2 PLoS One
1 Radiol Imaging Cancer
2 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. ZHANG G, Xu X, Hong R, Han X, et al
    An explainable radiomics model based on multiparametric magnetic resonance for differentiating benign and malignant orbital tumors.
    BMC Cancer. 2026 Mar 13. doi: 10.1186/s12885-026-15853.
    PubMed         Abstract available

  2. INCHANALKAR M, Chavda R, Gawde J, Patil A, et al
    Upregulation of Derlin 3 (DERL3) protein expression is associated with Oral Cancer progression and is independent of promoter hypermethylation.
    BMC Cancer. 2026 Mar 13. doi: 10.1186/s12885-026-15856.
    PubMed        

  3. KHALID Z, Khan K, Nazir F, Yao C, et al
    Identification and validation of hub genes involved in papillary thyroid carcinoma progression.
    BMC Cancer. 2026 Mar 19. doi: 10.1186/s12885-026-15841.
    PubMed        

  4. YUAN CH, Ke HL, Jhan JH, Chu TH, et al
    High VRK2 expression level predicts unfavorable survival outcomes in nasopharyngeal carcinoma.
    BMC Cancer. 2026 Mar 13. doi: 10.1186/s12885-026-15804.
    PubMed        


    BMC Surg

  5. PENG Z, Shuai M, Zhang L, Wang X, et al
    Nasopharyngeal carcinoma radiation-induced sarcoma in the skull base: a retrospective follow-up cohort study.
    BMC Surg. 2026 Mar 18. doi: 10.1186/s12893-026-03669.
    PubMed        


    Br J Cancer

  6. HUANG TC, Guo JC, Lin CC, Kuo HY, et al
    Neoadjuvant immunochemoradiotherapy with nivolumab, paclitaxel, and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma.
    Br J Cancer. 2026 Mar 20. doi: 10.1038/s41416-026-03349.
    PubMed         Abstract available


    Br J Oral Maxillofac Surg

  7. FISHWICK M, Walker L, Chai A, Nelson C, et al
    Head and neck cancer risk predictive models: a solution to streamline urgent suspected cancer referrals?
    Br J Oral Maxillofac Surg. 2025 Nov 15:S0266-4356(25)00871.
    PubMed         Abstract available


    Cancer Res

  8. WU J, Chen C, Lv X, Wang Q, et al
    A Non-canonical RNA-Binding Function of NQO1 Drives Angiogenesis in Esophageal Squamous Cell Carcinoma via Extracellular Vesicle-Mediated AGRN Transfer.
    Cancer Res. 2026 Mar 16. doi: 10.1158/0008-5472.CAN-25-4415.
    PubMed         Abstract available


    Clin Cancer Res

  9. CHIRRA M, Elliott A, Shaikh H, McGrath J, et al
    Molecular Profiling and Real-World Outcomes of BRAF V600E-Mutated Papillary Thyroid Cancer.
    Clin Cancer Res. 2026 Jan 16. doi: 10.1158/1078-0432.CCR-25-3932.
    PubMed         Abstract available

  10. ANDERSON JL, Sikora AG
    Neoadjuvant chemoimmunotherapy improves response rates in head and neck cancer.
    Clin Cancer Res. 2026 Mar 17. doi: 10.1158/1078-0432.CCR-25-4813.
    PubMed         Abstract available

  11. GOLFINOS-OWENS AE, Lozar T, Khatri P, Johns ED, et al
    Integrated single-cell and spatial analysis reveals context-dependent myeloid-T cell interactions in response to immune checkpoint blockade in head and neck cancer.
    Clin Cancer Res. 2026 Mar 16. doi: 10.1158/1078-0432.CCR-25-2300.
    PubMed         Abstract available


    Dis Esophagus

  12. SPATARO J, Fuchs M, Zfass A
    Clinical tips to optimize liquid nitrogen spray cryotherapy in esophageal malignancy.
    Dis Esophagus. 2026;39:doag024.
    PubMed         Abstract available


    Gastrointest Endosc

  13. YADAV A, Gupta S, Karim S, Banh X, et al
    Utility of random neosquamous and cardia biopsy specimens during surveillance after dysplastic Barrett's eradication: a prospective single-center study.
    Gastrointest Endosc. 2026;103:700-708.
    PubMed         Abstract available


    Head Neck

  14. LI Y, Zhou Y, Liu X, Yang X, et al
    Exploring the Dynamics of Postoperative Radiotherapy Symptom Networks in Oral Cancer Patients: A Cross-Lagged Panel Network Analysis.
    Head Neck. 2026 Mar 13. doi: 10.1002/hed.70236.
    PubMed         Abstract available

  15. ALLEN DZ, Hosseini SM, Zafereo M, Lango M, et al
    Deceptive Thyroid Pathologies: Anaplastic Thyroid Carcinoma Mimics and Clinical Implications.
    Head Neck. 2026 Mar 15. doi: 10.1002/hed.70201.
    PubMed         Abstract available

  16. WANG Z, Zhang F, Zhou Q, Zhang X, et al
    Surgical Management of Right Innominate Interarteriovenous Lymph Node Metastasis in Thyroid Carcinoma: Clinical Features and Operative Experience.
    Head Neck. 2026 Mar 20. doi: 10.1002/hed.70239.
    PubMed         Abstract available

  17. KATOH M, Eguchi K, Ito T, Tanaka A, et al
    History of Head and Neck Cancer as a Predictor of Recurrence and Second Primary Tumors After Transoral Videolaryngoscopic Surgery in Patients With Hypopharyngeal Squamous Cell Carcinoma.
    Head Neck. 2026 Mar 20. doi: 10.1002/hed.70242.
    PubMed         Abstract available


    Int J Cancer

  18. MASETTI M, Petrelli F, Pietrantonio F, Lorenzen S, et al
    Immunotherapy in advanced gastroesophageal cancers: A meta-analysis of sex-based outcomes in overall survival.
    Int J Cancer. 2026;158:2697-2708.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  19. XIE C, Shen Y, He J, Guo M, et al
    Pretreatment Radiation Esophagitis Prediction using Quantum Machine Learning in Esophageal Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2026 Mar 16:S0360-3016(26)00494.
    PubMed         Abstract available

  20. JI P, Shen J, He D, Chen L, et al
    Combined Real-time Liquid Biopsy with TNM Stage to Guide Induction Chemotherapy Cycles in Nasopharyngeal Carcinoma: A Development and Validation Study.
    Int J Radiat Oncol Biol Phys. 2026 Mar 12:S0360-3016(26)00493.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  21. RITTER A, Eagan A, Levyn H, Tuttle RM, et al
    Comparable Outcomes of Differentiated Thyroid Cancer in Immunocompromised versus Immunocompetent Patients.
    J Clin Endocrinol Metab. 2025 Oct 7:dgaf550. doi: 10.1210.
    PubMed         Abstract available

  22. NAKATANI R, Watabe T, Fukuhara A, Takano T, et al
    Initial evaluation of radioiodine therapy using Imaging for long-term prognosis in thyroid cancer: A retrospective study.
    J Clin Endocrinol Metab. 2025 Oct 15:dgaf568. doi: 10.1210.
    PubMed         Abstract available

  23. FINNEGAN EA, Ganly I
    Approach to the Patient: Oncocytic Thyroid Cancer.
    J Clin Endocrinol Metab. 2026 Jan 28:dgag025. doi: 10.1210.
    PubMed         Abstract available

  24. HABIB S, Perez Rodriguez Garcia G, Zhang Z, Roy A, et al
    Determining Thyroid Biopsy Appropriateness: A Retrospective Study Integrating Clinical Context and Ultrasound Features.
    J Clin Endocrinol Metab. 2025 Oct 24:dgaf577. doi: 10.1210.
    PubMed         Abstract available

  25. GAMBELUNGHE G, Del Sindaco P, Morettini F, Ristagno S, et al
    Percutaneous Laser Ablation for Thyroid Nodules: Efficacy and Safety in 1,492 Patients with Median Follow-up >/= 10 Years.
    J Clin Endocrinol Metab. 2025 Oct 24:dgaf581. doi: 10.1210.
    PubMed         Abstract available


    J Clin Oncol

  26. MIRGHANI H, Auperin A, Even C, Larive A, et al
    Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial.
    J Clin Oncol. 2026;44:787-800.
    PubMed         Abstract available

  27. LIU Z, Liu X, Li Z, Xie J, et al
    Fullerene for Reducing Acute Radiation Dermatitis in Patients Undergoing Radiotherapy for Head and Neck Cancer: A Phase II, Double-Blind, Randomized Controlled Trial.
    J Clin Oncol. 2026 Mar 20:JCO2502264. doi: 10.1200/JCO-25-02264.
    PubMed         Abstract available


    Laryngoscope

  28. HWANG SH, Lin ME, St John M
    What Is the Effectiveness of Tocopherol and Pentoxifylline in the Treatment of Osteoradionecrosis of the Mandible?
    Laryngoscope. 2026;136:1563-1565.
    PubMed         Abstract available

  29. PALATNIK B, Mortensen L, Palatnik A, Wuertz BR, et al
    Longitudinal Analysis of Oral Potentially Malignant Disorder Conversion to Malignancy.
    Laryngoscope. 2026;136:1755-1761.
    PubMed         Abstract available

  30. ZHENG Y, Zhang D, Sun Q, Lu J, et al
    Refining Prognostic Predictions and Risk Assessment in Head and Neck Rhabdomyosarcoma.
    Laryngoscope. 2026;136:1668-1682.
    PubMed         Abstract available

  31. BAYRAKTAR FGI, Celik RC, Kulduk G
    Tonsillar Olfactory Neuroblastoma With Cervical Node Involvement: A Rare Case and Literature Review.
    Laryngoscope. 2026;136:1780-1783.
    PubMed         Abstract available

  32. SHANG T, Cabrera CI, Kominsky RA, Fowler N, et al
    Total Laryngectomy Length of Stay Association With Diagnosis Related Group Classification.
    Laryngoscope. 2026;136:1770-1779.
    PubMed         Abstract available

  33. PATEL N, Reynoso N, Heaton C, Likhterov I, et al
    EPIDERM Technique: Safety and Outcomes of Skin Grafted Free Flaps in Head and Neck Reconstruction.
    Laryngoscope. 2026;136:1727-1733.
    PubMed         Abstract available

  34. STACK TJ, Henrich J, Buckmire RA, Shah RN, et al
    Missed Opportunities: Laryngologists and Lung Cancer Screening in Early Glottic Cancer Patients.
    Laryngoscope. 2026;136:1815-1821.
    PubMed         Abstract available

  35. KIM AH, Tham T, Giannaris PS, Kokabee M, et al
    Sinonasal Inverted Papilloma and Clinical Significance of Dysplasia: A Multi-Institutional Study.
    Laryngoscope. 2026;136:1656-1664.
    PubMed         Abstract available


    Oral Oncol

  36. SHAHID F, Mohsin AR, Rahman UA, Warraich AA, et al
    Thyroglossal duct cyst carcinoma: A case report about diagnostic and surgical challenges.
    Oral Oncol. 2026;175:107890.
    PubMed         Abstract available

  37. TOPKAN E, Selek U
    Comment on low-dose fractionated radiotherapy during induction chemotherapy for node-positive locoregionally advanced nasopharyngeal carcinoma: a randomized phase II trial.
    Oral Oncol. 2026;176:107940.
    PubMed        

  38. KASAHARA K, Kono T, Sato Y, Okubo K, et al
    Risk-benefit stratification for immune checkpoint inhibitor therapy in head and neck cancer based on immune-related adverse events and treatment discontinuation using routine clinical indicators beyond PD-L1 expression.
    Oral Oncol. 2026;176:107938.
    PubMed         Abstract available

  39. KOCH N, Yosefof E, Gleber-Netto FO, Amir I, et al
    Elective neck irradiation does not improve regional control or survival in pT3-T4N0 oral cavity SCC after high-yield neck dissection: A retrospective multicenter analysis.
    Oral Oncol. 2026;176:107946.
    PubMed         Abstract available

  40. LEE SF, Hircock C, Yip PL, Cheo T, et al
    Limitations of quality-of-life assessment and long-term side effects in nasopharyngeal carcinoma: a narrative review.
    Oral Oncol. 2026;176:107935.
    PubMed         Abstract available


    PLoS One

  41. PAN D, Diao YX, Pan YX, Ai ZH, et al
    Global burden and temporal trend of thyroid cancer associated with high BMI from 1990 to 2021.
    PLoS One. 2026;21:e0343394.
    PubMed         Abstract available

  42. LIU W, Yang J, Zheng Z, Yu Y, et al
    Spatial and temporal distribution of thyroid cancer incidence in China: An ecological study based on a national registry.
    PLoS One. 2026;21:e0341734.
    PubMed         Abstract available


    Radiol Imaging Cancer

  43. SISTONEN HJ, Markkola AT, Aro K, Kurdo G, et al
    Diagnostic Accuracy of PET/CT and Diffusion-weighted MRI in Detecting Residual Oropharyngeal Carcinoma after Chemoradiotherapy.
    Radiol Imaging Cancer. 2026;8:e250351.
    PubMed         Abstract available


    Radiother Oncol

  44. RAO M, Liao J, Li X, Long L, et al
    Oscillatory and recurrent drivers of symptom networks in head and neck cancer radiotherapy: a longitudinal cross-lagged panel network study.
    Radiother Oncol. 2026 Mar 17:111487. doi: 10.1016/j.radonc.2026.111487.
    PubMed         Abstract available

  45. MACRAE DC, van der Hoek L, de Vette SPM, Neh H, et al
    A multi-toxicity deep learning approach for normal tissue complication probability modelling in head and neck cancer patients receiving radiotherapy.
    Radiother Oncol. 2026 Mar 17:111486. doi: 10.1016/j.radonc.2026.111486.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum